Blood Testing Market (By Test Type: Glucose Testing, A1C Testing, Direct LDL Testing, Lipid Panel Testing, Prostate-specific Antigen Testing, COVID-19 Testing, BUN Testing, Vitamin D Testing, Thyroid-stimulating Hormone (TSH), Serum Nicotine/Cotinine, High-sensitivity CRP Testing, Testosterone Testing, ALT Testing, Cortisol Testing, Creatinine Testing, AST Testing, Other Blood Tests, and Others.) - Global Industry Analysis, Size, Share, Growth, Trends, Regional Outlook, and Forecast 2024-2033
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
3.1. Market Snapshot
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
5.1. COVID-19 Landscape: Blood Testing Industry Impact
5.2. COVID 19 - Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
8.1. Blood Testing Market, by Test Type, 2024-2033
8.1.1. Glucose Testing
8.1.1.1. Market Revenue and Forecast (2021-2033)
8.1.2. A1C Testing
8.1.2.1. Market Revenue and Forecast (2021-2033)
8.1.3. Direct LDL Testing
8.1.3.1. Market Revenue and Forecast (2021-2033)
8.1.4. Lipid Panel Testing
8.1.4.1. Market Revenue and Forecast (2021-2033)
8.1.5. Prostate-specific Antigen Testing
8.1.5.1. Market Revenue and Forecast (2021-2033)
8.1.6. COVID-19 Testing
8.1.6.1. Market Revenue and Forecast (2021-2033)
8.1.7. BUN Testing
8.1.7.1. Market Revenue and Forecast (2021-2033)
8.1.8. Vitamin D Testing
8.1.8.1. Market Revenue and Forecast (2021-2033)
8.1.9. Thyroid-stimulating Hormone (TSH)
8.1.9.1. Market Revenue and Forecast (2021-2033)
8.1.10. Serum Nicotine/Cotinine
8.1.10.1. Market Revenue and Forecast (2021-2033)
8.1.11. High-sensitivity CRP Testing
8.1.11.1. Market Revenue and Forecast (2021-2033)
8.1.12. Testosterone Testing
8.1.12.1. Market Revenue and Forecast (2021-2033)
8.1.13. ALT Testing
8.1.13.1. Market Revenue and Forecast (2021-2033)
8.1.14. Cortisol Testing
8.1.14.1. Market Revenue and Forecast (2021-2033)
8.1.15. Creatinine Testing
8.1.15.1. Market Revenue and Forecast (2021-2033)
8.1.16. AST Testing
8.1.16.1. Market Revenue and Forecast (2021-2033)
8.1.17. Other Blood Tests
8.1.17.1. Market Revenue and Forecast (2021-2033)
9.1. North America
9.1.1. Market Revenue and Forecast, by Test Type (2021-2033)
9.1.2. U.S.
9.1.2.1. Market Revenue and Forecast, by Test Type (2021-2033)
9.1.3. Rest of North America
9.1.3.1. Market Revenue and Forecast, by Test Type (2021-2033)
9.2. Europe
9.2.1. Market Revenue and Forecast, by Test Type (2021-2033)
9.2.2. UK
9.2.2.1. Market Revenue and Forecast, by Test Type (2021-2033)
9.2.3. Germany
9.2.3.1. Market Revenue and Forecast, by Test Type (2021-2033)
9.2.4. France
9.2.4.1. Market Revenue and Forecast, by Test Type (2021-2033)
9.2.5. Rest of Europe
9.2.5.1. Market Revenue and Forecast, by Test Type (2021-2033)
9.3. APAC
9.3.1. Market Revenue and Forecast, by Test Type (2021-2033)
9.3.2. India
9.3.2.1. Market Revenue and Forecast, by Test Type (2021-2033)
9.3.3. China
9.3.3.1. Market Revenue and Forecast, by Test Type (2021-2033)
9.3.4. Japan
9.3.4.1. Market Revenue and Forecast, by Test Type (2021-2033)
9.3.5. Rest of APAC
9.3.5.1. Market Revenue and Forecast, by Test Type (2021-2033)
9.4. MEA
9.4.1. Market Revenue and Forecast, by Test Type (2021-2033)
9.4.2. GCC
9.4.2.1. Market Revenue and Forecast, by Test Type (2021-2033)
9.4.3. North Africa
9.4.3.1. Market Revenue and Forecast, by Test Type (2021-2033)
9.4.4. South Africa
9.4.4.1. Market Revenue and Forecast, by Test Type (2021-2033)
9.4.5. Rest of MEA
9.4.5.1. Market Revenue and Forecast, by Test Type (2021-2033)
9.5. Latin America
9.5.1. Market Revenue and Forecast, by Test Type (2021-2033)
9.5.2. Brazil
9.5.2.1. Market Revenue and Forecast, by Test Type (2021-2033)
9.5.3. Rest of LATAM
9.5.3.1. Market Revenue and Forecast, by Test Type (2021-2033)
10.1. Abbott
10.1.1. Company Overview
10.1.2. Product Offerings
10.1.3. Financial Performance
10.1.4. Recent Initiatives
10.2. F. Hoffmann-La Roche AG
10.2.1. Company Overview
10.2.2. Product Offerings
10.2.3. Financial Performance
10.2.4. Recent Initiatives
10.3. Bio-Rad Laboratories, Inc.
10.3.1. Company Overview
10.3.2. Product Offerings
10.3.3. Financial Performance
10.3.4. Recent Initiatives
10.4. BioMerieux SA
10.4.1. Company Overview
10.4.2. Product Offerings
10.4.3. Financial Performance
10.4.4. Recent Initiatives
10.5. Quest Diagnostics
10.5.1. Company Overview
10.5.2. Product Offerings
10.5.3. Financial Performance
10.5.4. Recent Initiatives
10.6. Biomerica, Inc.
10.6.1. Company Overview
10.6.2. Product Offerings
10.6.3. Financial Performance
10.6.4. Recent Initiatives
10.7. Becton, Dickinson and Company
10.7.1. Company Overview
10.7.2. Product Offerings
10.7.3. Financial Performance
10.7.4. Recent Initiatives
10.8. Siemens Healthineers
10.8.1. Company Overview
10.8.2. Product Offerings
10.8.3. Financial Performance
10.8.4. Recent Initiatives
10.9. Danaher Corporation
10.9.1. Company Overview
10.9.2. Product Offerings
10.9.3. Financial Performance
10.9.4. Recent Initiatives
10.10. Trinity Biotech Plc
10.10.1. Company Overview
10.10.2. Product Offerings
10.10.3. Financial Performance
10.10.4. Recent Initiatives
11.1. Primary Research
11.2. Secondary Research
11.3. Assumptions
12.1. About Us
12.2. Glossary of Terms
No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client
Report Description
Get a Sample